T. Rowe Price Associates’s Invacare Corporation IVC Stock Holding History

T. Rowe Price Associates’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-90,300	Closed	-$71K	–	3020
2022 Q3	$71K	Buy	90,300 +26,000	+40%	+$27.4K	﹤0.01%	2789
2022 Q2	$82K	Buy	64,300 +6,043	+10%	+$7.96K	﹤0.01%	2799
2022 Q1	$82K	Sell	58,257 -16,600	-22%	-$35.5K	﹤0.01%	2875
2021 Q4	$204K	Buy	74,857 +36,200	+94%	+$133K	﹤0.01%	2753
2021 Q3	$184K	Hold	38,657	–	–	﹤0.01%	2745
2021 Q2	$312K	Buy	38,657 +640	+2%	+$5.33K	﹤0.01%	2585
2021 Q1	$305K	Sell	38,017 -8,498	-18%	-$79.2K	﹤0.01%	2562
2020 Q4	$416K	Sell	46,515 -200	-0.4%	-$1.66K	﹤0.01%	2316
2020 Q3	$351K	Sell	46,715 -5,600	-11%	-$38.8K	﹤0.01%	2231
2020 Q2	$333K	Sell	52,315 -21,612	-29%	-$145K	﹤0.01%	2216
2020 Q1	$549K	Buy	73,927 +210	+0.3%	+$1.63K	﹤0.01%	1940
2019 Q4	$665K	Sell	73,717 -38,568	-34%	-$324K	﹤0.01%	2059
2019 Q3	$842K	Sell	112,285 -17,760	-14%	-$99.6K	﹤0.01%	1891
2019 Q2	$675K	Buy	130,045 +35,800	+38%	+$233K	﹤0.01%	2000
2019 Q1	$789K	Sell	94,245 -32,500	-26%	-$234K	﹤0.01%	1942
2018 Q4	$545K	Buy	126,745 +107,665	+564%	+$952K	﹤0.01%	2045
2018 Q3	$278K	Sell	19,080 -302	-2%	-$5K	﹤0.01%	2378
2018 Q2	$361K	Buy	19,382 +36	+0.2%	+$651	﹤0.01%	2283
2018 Q1	$337K	Buy	19,346 +63	+0.3%	+$1.11K	﹤0.01%	2241
2017 Q4	$325K	Sell	19,283 -17	-0.1%	-$277	﹤0.01%	2252
2017 Q3	$304K	Hold	19,300	–	–	﹤0.01%	2284
2017 Q2	$255K	Hold	19,300	–	–	﹤0.01%	2293
2017 Q1	$230K	Sell	19,300 -17,500	-48%	-$210K	﹤0.01%	2348
2016 Q4	$480K	Hold	36,800	–	–	﹤0.01%	2061
2016 Q3	$411K	Buy	36,800 +11,000	+43%	+$132K	﹤0.01%	2084
2016 Q2	$313K	Sell	25,800 -9,800	-28%	-$116K	﹤0.01%	2151
2016 Q1	$469K	Buy	35,600 +20,000	+128%	+$284K	﹤0.01%	1999
2015 Q4	$271K	Buy	15,600 +100	+0.6%	+$1.8K	﹤0.01%	2196
2015 Q3	$224K	Hold	15,500	–	–	﹤0.01%	2256
2015 Q2	$335K	Hold	15,500	–	–	﹤0.01%	2157
2015 Q1	$301K	Hold	15,500	–	–	﹤0.01%	2189
2014 Q4	$260K	Hold	15,500	–	–	﹤0.01%	2237
2014 Q3	$183K	Hold	15,500	–	–	﹤0.01%	2371
2014 Q2	$285K	Hold	15,500	–	–	﹤0.01%	2204
2014 Q1	$296K	Hold	15,500	–	–	﹤0.01%	2160
2013 Q4	$360K	Hold	15,500	–	–	﹤0.01%	2061
2013 Q3	$268K	Hold	15,500	–	–	﹤0.01%	2158
2013 Q2	$223K	Buy	+15,500	New	+$215K	﹤0.01%	2180

Other funds holding IVC

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AGAM

Audent Global Asset Management West Hollywood, California $89.6M AUM 29.78% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates's IVC Position: Q4 2022 in Review

T. Rowe Price Associates sold out of Invacare Corporation (IVC) in Q4 2022, closing a stake of 90,300 shares — an estimated $71K sold.

T. Rowe Price Associates first reported a position in IVC in Q2 2013 and held it in 38 quarters. The position peaked at $842K in Q3 2019. 66 funds tracked by Wall St. Rank hold IVC as of Q4 2022.

T. Rowe Price Associates reported no remaining Invacare Corporation position as of Q4 2022 after selling out during the quarter.
T. Rowe Price Associates sold 90,300 Invacare Corporation shares in Q4 2022, an estimated $71K.
T. Rowe Price Associates first reported a position in Invacare Corporation in Q2 2013 and held it in 38 quarters.
T. Rowe Price Associates's Invacare Corporation position peaked at $842K in Q3 2019.
66 funds tracked by Wall St. Rank held Invacare Corporation as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.